UBS Group Has Lowered Expectations for AdaptHealth (NASDAQ:AHCO) Stock Price

AdaptHealth (NASDAQ:AHCO) had its price target lowered by investment analysts at UBS Group from $12.00 to $11.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price target points to a potential upside of 25.28% from the stock’s current price.

Several other research analysts also recently commented on the stock. Truist Financial cut their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 15th. Robert W. Baird cut their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a report on Wednesday, November 6th. Canaccord Genuity Group cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Finally, Royal Bank of Canada dropped their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a report on Tuesday, November 19th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, AdaptHealth currently has a consensus rating of “Buy” and a consensus price target of $12.20.

AdaptHealth Stock Down 1.7 %

AdaptHealth stock opened at $8.78 on Thursday. AdaptHealth has a 1-year low of $7.01 and a 1-year high of $11.90. The firm has a market capitalization of $1.18 billion, a price-to-earnings ratio of -5.32, a P/E/G ratio of 1.23 and a beta of 1.12. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The firm has a 50 day simple moving average of $9.95 and a 200 day simple moving average of $10.28.

Institutional Trading of AdaptHealth

A number of hedge funds have recently made changes to their positions in AHCO. Assetmark Inc. bought a new stake in AdaptHealth in the fourth quarter worth $28,000. Blue Trust Inc. increased its position in shares of AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares during the period. Quarry LP increased its position in shares of AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after acquiring an additional 5,838 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its position in shares of AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares during the period. Finally, CIBC Asset Management Inc purchased a new position in shares of AdaptHealth in the third quarter valued at about $122,000. 82.67% of the stock is owned by institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.